PET and PET/CT with radiolabeled choline in prostate cancer: a critical reappraisal of 20 years of clinical studies.

about

Current status of theranostics in prostate cancer.Therapy monitoring with PET in cancer patients: achievements, opportunities and challenges ahead for the PET community.Liver metastases from prostate cancer at 11C-Choline PET/CT: a multicenter, retrospective analysis.

P2860

Q47241139-56942847-20E2-4D12-881E-701C8B9BB370 Q48105701-21E53D19-7CD6-4EB7-A357-FC5C5F90E349 Q48205881-BF972A42-2E41-4719-9468-186247CEA1E7

P2860

PET and PET/CT with radiolabeled choline in prostate cancer: a critical reappraisal of 20 years of clinical studies.

Item

http://www.wikidata.org/entity/Q39242140

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

PET and PET/CT with radiolabel ...... 20 years of clinical studies.

@en

PET and PET/CT with radiolabel ...... 20 years of clinical studies.

@nl

type

Item

label

PET and PET/CT with radiolabel ...... 20 years of clinical studies.

@en

PET and PET/CT with radiolabel ...... 20 years of clinical studies.

@nl

prefLabel

PET and PET/CT with radiolabel ...... 20 years of clinical studies.

@en

PET and PET/CT with radiolabel ...... 20 years of clinical studies.

@nl

P1476

PET and PET/CT with radiolabel ...... 20 years of clinical studies.

@en

P2093

Andrea Ciarmiello

http://www.w3.org/2001/XMLSchema#string

Elisabetta Giovannini

http://www.w3.org/2001/XMLSchema#string

Giampiero Giovacchini

http://www.w3.org/2001/XMLSchema#string

Mattia Riondato

http://www.w3.org/2001/XMLSchema#string

Rossella Leoncini

http://www.w3.org/2001/XMLSchema#string

P2860

Multiparametric Magnetic Resonance Imaging of Recurrent Prostate Cancer

Cancer statistics, 2010

Overexpression of choline kinase is a frequent feature in human tumor-derived cell lines and in lung, prostate, and colorectal human cancers

Alpha emitter radium-223 and survival in metastatic prostate cancer

Clinical applications of choline PET/CT in brain tumors.

PET/CT with (11)C-choline for evaluation of prostate cancer patients with biochemical recurrence: meta-analysis and critical review of available data.

Evaluation of [(18)F]-choline PET/CT for staging and restaging of prostate cancer.

177Lu-Labeled Prostate-Specific Membrane Antigen Radioligand Therapy of Metastatic Castration-Resistant Prostate Cancer: Safety and Efficacy.

Choline PET for monitoring early tumor response to photodynamic therapy

Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group.

P2888

s00259-017-3700-x

P304

1751-1776

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00259-017-3700-X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-04-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28409220

http://www.w3.org/2001/XMLSchema#string

PET and PET/CT with radiolabeled choline in prostate cancer: a critical reappraisal of 20 years of clinical studies.

about

P2860

P2860

PET and PET/CT with radiolabeled choline in prostate cancer: a critical reappraisal of 20 years of clinical studies.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698